Abstract
In this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously failed. Thirty-three patients were randomized to receive either regimen OAC (20 mg omeprazole, 750 mg amoxicillin, and 250 mg clarithromycin) or BTC (240 mg bismuth subcitrate, 750 mg oxytetracycline, and 250 mg clarithromycin), all twice daily for 10 days. A further 28 patients were all treated with OAC. Previously failed therapy included combinations of bismuth (B), omeprazole (O), tetracycline (T), metronidazole (M), amoxicillin (A), or clarithromycin (C) in BTM (n = 48), OAM (n = 13), OA (n = 7), OCM (n = 2), or BCM (n = 1). H. pylori infection was confirmed by culture of biopsy specimens, and antimicrobial susceptibility testing was performed with the E test. H. pylori infection was cured in all patients (n = 18) with OAC and in 8 patients (53%) with BTC (P = 0.001) in the randomized group and in 27 patients (96%) receiving OAC in the open-label group. Ten-day OAC is highly effective and superior to BTC in patients in whom metronidazole-based treatment has previously failed.
References
Oct 1, 1995·Gut·T J BorodyH Bae
Feb 1, 1995·Alimentary Pharmacology & Therapeutics·G D BellC Brown
Feb 1, 1994·Alimentary Pharmacology & Therapeutics·J C ThijsE A Runhaar
Oct 1, 1995·Alimentary Pharmacology & Therapeutics·T G ReillyR P Walt
Oct 1, 1995·Alimentary Pharmacology & Therapeutics·G D BellM D Taylor
Apr 1, 1996·Alimentary Pharmacology & Therapeutics·J LabenzG Börsch
Aug 24, 1996·Lancet·R P Walt
Jun 1, 1996·Alimentary Pharmacology & Therapeutics·J C DelchierJ P Idström
Aug 1, 1996·Alimentary Pharmacology & Therapeutics·M M YousfiD Y Graham
Feb 1, 1996·Alimentary Pharmacology & Therapeutics·M M YousfiD Y Graham
Dec 1, 1996·Alimentary Pharmacology & Therapeutics·M MoshkowitzT Gilat
Dec 1, 1996·Alimentary Pharmacology & Therapeutics·L LaineG Neil
Sep 1, 1996·Helicobacter·T LindJ P Idström
Mar 1, 1996·Helicobacter·R W van der HulstG N Tytgat
Citations
Nov 2, 2006·Digestive Diseases and Sciences·Jacob YahavHaim Shmuely
Mar 12, 2003·Current Treatment Options in Gastroenterology·Javier P. Gisbert, José María Pajares
Feb 20, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J P GisbertJ M Pajares
Oct 22, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F ParenteG Bianchi Porro
Feb 1, 1997·Alimentary Pharmacology & Therapeutics·J LabenzM Stolte
Feb 1, 1997·Alimentary Pharmacology & Therapeutics·J LabenzG Börsch
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·F PerriA Andriulli
May 29, 2002·Alimentary Pharmacology & Therapeutics·J P Gisbert, J M Pajares
Apr 18, 2002·Journal of Clinical Gastroenterology·Chiun-Ku LinPing-Ning Hsu
Dec 1, 1996·Helicobacter·D S RiffN Siepman
Apr 27, 2012·Gastroenterology Research and Practice·Javier P Gisbert
Sep 23, 2008·World Journal of Gastroenterology : WJG·Javier P Gisbert
May 30, 1998·Scandinavian Journal of Gastroenterology·F LerangA Bjørneklett
May 9, 2008·Expert Opinion on Drug Safety·Avelyn KwokRupert Wl Leong
Mar 5, 2011·Gastroenterología y hepatología·Javier P Gisbert
Mar 5, 2016·Middle East Journal of Digestive Diseases·Hafez FakheriSaman Alhooei
Sep 11, 1998·The American Journal of Gastroenterology·K M ChuJ Wong
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Javier P Gisbert
Feb 19, 1998·The American Journal of Gastroenterology·F LerangT Berge
Feb 24, 2001·The American Journal of Gastroenterology·F PerriA Andriulli
May 16, 2006·Digestive Diseases·Francesco Di MarioCarmelo Scarpignato
Jul 18, 2014·World Journal of Gastrointestinal Endoscopy·Teresa GarridoFauze Maluf-Filho
Oct 16, 1999·Scandinavian Journal of Gastroenterology·S Olafsson, A Berstad
Jan 14, 2005·European Journal of Gastroenterology & Hepatology·Perttu Et ArkkilaMartti Färkkilä
Nov 4, 2000·Scandinavian Journal of Gastroenterology·K SeppäläT A Miettinen
Aug 26, 1998·Scandinavian Journal of Gastroenterology·F LerangA Bjørneklett